<div><div><h2>Sharon Bio Medi Standalone September 2018 Net Sales at Rs 39.18 crore, up 25.53% Y-o-Y</h2></div><div>"reported standalone quarterly numbers for sharon bio medicine are:net sales at rs 39.18 crore in september 2018 up 25.53% from rs. 31.21 crore in september 2017.quarterly net profit at rs. 3.17 crore in september 2018 up 737.01% from rs. 0.38 crore in september 2017.ebitda stands at rs. 5.85 crore in september 2018 up 68.1% from rs. 3.48 crore in september 2017.sharon bio medi eps has increased to rs. 0.27 in september 2018 from rs. 0.03 in september 2017.sharon bio medi shares closed at 5.20 on november 14 2018 (nse) and has given 4.00% returns over the last 6 months and -25.18% over the last 12 months.sharon bio medicinestandalone quarterly resultsin rs. cr.sep'18jun'18sep'17net sales/income from operations37.7231.2731.08other operating income1.472.120.13total income from operations39.1833.4031.21expenditureconsumption of raw materials21.0115.7017.83purchase of traded goods------increase/decrease in stocks-1.26-1.89-3.82power &  fuel------employees cost6.485.945.66depreciation2.732.713.03excise duty------admin. and selling expenses------r &  d expenses------provisions and contingencies------exp. capitalised------other expenses8.187.168.07p/l before other inc.  int. excpt. items &  tax2.033.770.44other income1.090.770.01p/l before int. excpt. items &  tax3.124.550.45interest----0.07p/l before exceptional items &  tax3.124.550.38exceptional items0.05-0.140.00p/l before tax3.174.410.38tax------p/l after tax from ordinary activities3.174.410.38prior year adjustments------extra ordinary items------net profit/(loss) for the period3.174.410.38equity share capital23.7923.7923.79reserves excluding revaluation reserves------equity dividend rate (%)------eps before extra ordinarybasic eps0.270.370.03diluted eps0.270.370.03eps after extra ordinarybasic eps0.270.370.03diluted eps0.270.370.03public share holdingno of shares (crores)------share holding (%)------promoters and promoter group shareholdinga) pledged/encumbered- number of shares (crores)------- per. of shares (as a % of the total sh. of prom. and promoter group)------- per. of shares (as a % of the total share cap. of the company)------b) non-encumbered- number of shares (crores)------- per. of shares (as a % of the total sh. of prom. and promoter group)------- per. of shares (as a % of the total share cap. of the company)------source :  dion global solutions limited"</div></div>